Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Acalabrutinib + Bendamustine + Rituximab is approved by both FDA and EMA for adult patients with previously untreated mantle cell lymphoma who are ineligible for autologous stem cell transplantation (1, 3)
The Food and Drug Administration granted traditional approval on January 16, 2025, for the use of acalabrutinib in combination with bendamustine and rituximab. This approval is specifically for adults with previously untreated [Mantle-Cell Lymphoma (MCL)](brain:/…